Pathology Services

Description

Provision of Pathology Services Lot 1: In 2019 the NHS Long Term Plan set out the key ambition that all pathology services in England would be part of a pathology network by 2023 (now April 2025). In response to this the Cheshire & Merseyside Pathology Network developed an Outline Business Case which detailed an ambitious Target Operating Model which consists of developing 3 pathology hubs which would work together to make the best use of the assets and capabilities available, and to deliver on the benefits to patient care that are available by working more closely together. These three hubs cover the following geographical areas: North Hub - Liverpool East Hub - Sefton, Knowsley, St Helens, Warrington & Halton South Hub - Cheshire West and the Wirral To meet the National and Local ambitions Warrington & Halton Teaching Hospitals NHS Foundation Trusts are seeking a provider to deliver the East Hub Pathology Service. This provider must be able to offer a single pathology service for the geographical area of the East hub (see table above) delivered through a hub and spoke model. The provider must be able to deliver a single pathology service which consists of a Central Hub, situated in the geographic area, and Essential Service Laboratories at Ormskirk Southport, St Helens, Warrington, and Halton hospitals. The provider must be able to deliver all aspects of: Cellular Pathology (Histopathology and Cytology), Mortuary Services, Blood Science (Chemistry, Haematology, and blood transfusion), Immunology and Microbiology pathology services within the Central Hub. The provider must be able to deliver Blood science (Chemistry, Haematology and blood transfusion) and a small number of Microbiology Screening (Blood Cultures and Cerebral Spinal Fluid) tests on site at the Essential Services Laboratories. To provide the service, all hospital sites will retain their current equipment from their current suppliers and so the provider will not be required to provide any equipment as part of this service. It is the intention to award under the Most Suitable Provider Process. The approximate lifetime value of the contract is £75m. This a new service.